Blog
-
Diabetes Week: 12th-18th June 2016
Diabetes is one of the fastest growing health threats in the UK, with the number of people living with this condition having doubled in the last 20 years. It is estimated that
June 14, 2016 -
Alzheimer’s Disease: Biosciences Leads the Way with Research & Development
We have all experienced the worry and panic of losing our car keys or that important document, or the frustration when you can’t remember the one item you went to the shop
May 20, 2016 -
Stroke Awareness Month: May 2016
May is the dedicated month for Stroke Awareness when the Stroke Association release campaigns in order to increase knowledge and raise essential funds for those affected by stroke. Randox Biosciences are supporting
May 10, 2016 -
Randox Biosciences release two new oncology biomarkers
We are delighted to introduce you to two new oncology biomarkers that we have recently added to our portfolio; IL-18* and M2-PK*. IL-18 IL-18 is a proinflammatory cytokine closely related to IL-1α
April 14, 2016 -
World Health Day 2016: Diabetes
World Health Day on April 7th will focus on Diabetes. Randox Biosciences are joining the campaign to raise awareness of the increasing levels of this disease around the world and the ways
April 7, 2016 -
Global healthcare provider Randox Health to become Official Partner of the Grand National Festival
Global innovative healthcare company, Randox Health, will become the new Official Partner of the world’s greatest race, the Grand National, and the three-day Grand National Festival staged at Aintree Racecourse, in a
March 8, 2016 -
Randox hosts Health Minister Simon Hamilton at Minister on the Move Event
A focus on pioneering innovation that improves wellbeing and enables preventative healthcare is at the heart of Randox Laboratories – that’s according to our Managing Director, Dr. Peter FitzGerald, who was speaking
January 7, 2016 -
SIMPLE SWAB TEST TAKING THE GUESS WORK OUT OF ANTIBIOTIC PRESCRIPTION
A simple swab test developed by UK scientists could help curb the antibiotic resistance pandemic. The test, developed by Randox Laboratories, which can rapidly detect and identify the cause of 21 respiratory
November 26, 2015 -
Randox Laboratories and Biosytems International announce completion of clinical trial and licencing for QuantiPlasmaTM antibodies for early lung cancer diagnostics
Randox Laboratories and Biosystems International today announced the beginning of clinical validation of a lung cancer early detection test. A recent clinical trial involving over 1100 samples has been carried out in
November 24, 2015 -
PROTECT YOUR FAMILY FROM EARLY HEART DISEASE WITH A SIMPLE BLOOD TEST
World’s most advanced targeted test for UK families with gene-mutation disorder One of the most common and most underdiagnosed inherited diseases – FH affects at least 120,000 people in the UK, yet
October 16, 2015
Categories
- Company News (39)
- Scientific News (13)
- Uncategorised (13)